399 related articles for article (PubMed ID: 7989591)
1. Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus.
Kelley DE; Simoneau JA
J Clin Invest; 1994 Dec; 94(6):2349-56. PubMed ID: 7989591
[TBL] [Abstract][Full Text] [Related]
2. Impaired postprandial glucose utilization in non-insulin-dependent diabetes mellitus.
Kelley D; Mokan M; Veneman T
Metabolism; 1994 Dec; 43(12):1549-57. PubMed ID: 7990710
[TBL] [Abstract][Full Text] [Related]
3. Multiple defects of both hepatic and peripheral intracellular glucose processing contribute to the hyperglycaemia of NIDDM.
Vaag A; Alford F; Henriksen FL; Christopher M; Beck-Nielsen H
Diabetologia; 1995 Mar; 38(3):326-36. PubMed ID: 7758880
[TBL] [Abstract][Full Text] [Related]
4. Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss.
Kelley DE; Goodpaster B; Wing RR; Simoneau JA
Am J Physiol; 1999 Dec; 277(6):E1130-41. PubMed ID: 10600804
[TBL] [Abstract][Full Text] [Related]
5. Interaction of carbohydrate and fat fuels in human skeletal muscle: impact of obesity and NIDDM.
Mandarino LJ; Consoli A; Jain A; Kelley DE
Am J Physiol; 1996 Mar; 270(3 Pt 1):E463-70. PubMed ID: 8638694
[TBL] [Abstract][Full Text] [Related]
6. Skeletal muscle utilization of free fatty acids in women with visceral obesity.
Colberg SR; Simoneau JA; Thaete FL; Kelley DE
J Clin Invest; 1995 Apr; 95(4):1846-53. PubMed ID: 7706491
[TBL] [Abstract][Full Text] [Related]
7. Turnover and splanchnic metabolism of free fatty acids and ketones in insulin-dependent diabetics at rest and in response to exercise.
Wahren J; Sato Y; Ostman J; Hagenfeldt L; Felig P
J Clin Invest; 1984 May; 73(5):1367-76. PubMed ID: 6715541
[TBL] [Abstract][Full Text] [Related]
8. Metabolic pathways of glucose in skeletal muscle of lean NIDDM patients.
Kelley DE; Mokan M; Mandarino LJ
Diabetes Care; 1993 Aug; 16(8):1158-66. PubMed ID: 8375246
[TBL] [Abstract][Full Text] [Related]
9. Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance.
Groop LC; Bonadonna RC; DelPrato S; Ratheiser K; Zyck K; Ferrannini E; DeFronzo RA
J Clin Invest; 1989 Jul; 84(1):205-13. PubMed ID: 2661589
[TBL] [Abstract][Full Text] [Related]
10. The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus.
Groop LC; Saloranta C; Shank M; Bonadonna RC; Ferrannini E; DeFronzo RA
J Clin Endocrinol Metab; 1991 Jan; 72(1):96-107. PubMed ID: 1986032
[TBL] [Abstract][Full Text] [Related]
11. Increased epinephrine and skeletal muscle responses to hypoglycemia in non-insulin-dependent diabetes mellitus.
Shamoon H; Friedman S; Canton C; Zacharowicz L; Hu M; Rossetti L
J Clin Invest; 1994 Jun; 93(6):2562-71. PubMed ID: 8200993
[TBL] [Abstract][Full Text] [Related]
12. Intracellular lactate- and pyruvate-interconversion rates are increased in muscle tissue of non-insulin-dependent diabetic individuals.
Avogaro A; Toffolo G; Miola M; Valerio A; Tiengo A; Cobelli C; Del Prato S
J Clin Invest; 1996 Jul; 98(1):108-15. PubMed ID: 8690781
[TBL] [Abstract][Full Text] [Related]
13. Insulin-induced hexokinase II expression is reduced in obesity and NIDDM.
Pendergrass M; Koval J; Vogt C; Yki-Jarvinen H; Iozzo P; Pipek R; Ardehali H; Printz R; Granner D; DeFronzo RA; Mandarino LJ
Diabetes; 1998 Mar; 47(3):387-94. PubMed ID: 9519744
[TBL] [Abstract][Full Text] [Related]
14. Effect of the antilipolytic nicotinic acid analogue acipimox on whole-body and skeletal muscle glucose metabolism in patients with non-insulin-dependent diabetes mellitus.
Vaag A; Skött P; Damsbo P; Gall MA; Richter EA; Beck-Nielsen H
J Clin Invest; 1991 Oct; 88(4):1282-90. PubMed ID: 1918378
[TBL] [Abstract][Full Text] [Related]
15. Weight reduction and the impaired plasma-derived free fatty acid oxidation in type 2 diabetic subjects.
Blaak EE; Wolffenbuttel BH; Saris WH; Pelsers MM; Wagenmakers AJ
J Clin Endocrinol Metab; 2001 Apr; 86(4):1638-44. PubMed ID: 11297597
[TBL] [Abstract][Full Text] [Related]
16. Intracellular glucose oxidation and glycogen synthase activity are reduced in non-insulin-dependent (type II) diabetes independent of impaired glucose uptake.
Thorburn AW; Gumbiner B; Bulacan F; Wallace P; Henry RR
J Clin Invest; 1990 Feb; 85(2):522-9. PubMed ID: 2105341
[TBL] [Abstract][Full Text] [Related]
17. Intracellular glucose and fat metabolism in identical twins discordant for non-insulin-dependent diabetes mellitus (NIDDM): acquired versus genetic metabolic defects?
Vaag A; Alford F; Beck-Nielsen H
Diabet Med; 1996 Sep; 13(9):806-15. PubMed ID: 8891456
[TBL] [Abstract][Full Text] [Related]
18. Thiazolidinediones upregulate impaired fatty acid uptake in skeletal muscle of type 2 diabetic subjects.
Wilmsen HM; Ciaraldi TP; Carter L; Reehman N; Mudaliar SR; Henry RR
Am J Physiol Endocrinol Metab; 2003 Aug; 285(2):E354-62. PubMed ID: 12700163
[TBL] [Abstract][Full Text] [Related]
19. Fasting hyperglycemia normalizes oxidative and nonoxidative pathways of insulin-stimulated glucose metabolism in noninsulin-dependent diabetes mellitus.
Mandarino LJ; Consoli A; Kelley DE; Reilly JJ; Nurjhan N
J Clin Endocrinol Metab; 1990 Dec; 71(6):1544-51. PubMed ID: 2121778
[TBL] [Abstract][Full Text] [Related]
20. Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM.
Simoneau JA; Kelley DE
J Appl Physiol (1985); 1997 Jul; 83(1):166-71. PubMed ID: 9216960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
